Hypha Labs

Hypha Labs Gross Margin

The Gross Margin of Hypha Labs (FUNI) as of Oct 17, 2026 is 39.48 %. In the previous year, Gross Margin was 28.56 % — a change of 38.24% (higher).

Gross Margin

39.48 %

YoY

38.24%

Last updated:

Gross Margin of Hypha Labs is 2022 39.48 % . Gross Margin of Hypha Labs was 2021 28.56 % . It decreases by 38.24% higher compared to the previous year.

For Hypha Labs, the gross margin of 39.5% is up versus 27.1% a few years ago.

The Hypha Labs Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2015
-431.90 USD
Jan 1, 2016
53.57 USD
Jan 1, 2017
52.37 USD
Jan 1, 2018
27.12 USD
Jan 1, 2019
32.90 USD
Jan 1, 2020
30.92 USD
Jan 1, 2021
28.56 USD
Jan 1, 2022
39.48 USD
The Hypha Labs Gross Margin history
YEARGross MarginYoY
39.48 %+38.24%
28.56 %-7.62%
30.92 %-6.01%
32.90 %+21.31%
27.12 %-48.22%
52.37 %-2.24%
53.57 %-112.40%
-431.90 %-1,024.43%
46.72 %+9,966.86%
0.46 %+7.26%
0.43 %-56.73%
1.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hypha Labs Stock analysis

What does Hypha Labs do? Hypha Labs Inc, trading under the ticker symbol FUNI with ISIN US2538252022, is a United States-based entity operating within the Health Care sector. Headquartered in Las Vegas, Nevada, the company functions primarily as a service-oriented independent testing laboratory and data analytics firm. The organization maintains a relatively small workforce, employing 17 full-time staff members as of the latest available records. Hypha Labs Inc officially entered the public markets through an initial public offering on December 23, 2011. The company’s operational core is centered around its subsidiary, Digipath Labs, Inc., which serves as the primary vehicle for conducting cannabis-related testing services. This subsidiary utilizes FDA-compliant laboratory equipment and adheres to strict processing protocols to ensure the accuracy and safety of its analytical results. The firm positions itself as a critical third-party independent testing facility for a wide array of products, including medicinal and recreational cannabis, cannabis-infused products, hemp, and other botanical nutraceuticals. Its clientele is diverse, encompassing growers, dispensaries, caregivers, producers, patients, and ultimately, all end-users of cannabis and botanical products. The testing services provided by Digipath Labs are comprehensive, designed to screen products for various harmful contaminants that could pose risks to consumers. These contaminants include residual solvents, excessive moisture, and abnormal water activity levels. The laboratory also conducts thorough visual inspections to assess product quality and consistency. Furthermore, the facility tests for the presence of pesticides and heavy metals, which are common concerns in agricultural and botanical products. Biological toxins are another significant area of focus, with specific screening for aflatoxins and ochratoxins, which can be dangerous if ingested. Microbial contaminants are also rigorously tested for to ensure that the final products are safe for consumption. In addition to its testing capabilities, the company engages in providing education, training, and news coverage related to the cannabis industry, thereby supporting the broader ecosystem of stakeholders involved in botanical health and wellness. The company’s website, https://www.digipath.com/, serves as a hub for information regarding its services and industry insights. By maintaining independence and compliance with federal standards, Hypha Labs Inc aims to provide reliable data and safety assurances to a market that is increasingly regulated and consumer-focused. Hypha Labs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hypha Labs stock

Gross Margin of Hypha Labs is 39.48 % in 2022.

Gross Margin of Hypha Labs changed from 28.56 % to 39.48 %, representing a 38.24% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Hypha Labs since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Hypha Labs with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Hypha Labs

All Key Metrics — Hypha Labs